Register by June 12 to get the lowest rates for the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers (July 18-20, Vancouver), chaired by Andy Futreal, Taran Gujral, Brooke E. Howitt, and Patrick Tan. Learn more:
buff.ly/tYdYrqC
#AACRrarecancers26
Interested in setting up an estate plan but unsure how to get started? Cancer Today asked a cancer rights attorney to describe the different documents and how to begin the planning process. Read her response:
The Fellows of the AACR Academy Cancer Research Impact Grants are one-year, $75,000 awards that support early-career investigators nearing completion of postdoctoral or clinical research training. Apply by June 30. Learn more:
buff.ly/GeLhnOj
#AACRGrants
mAPMN/S prostate cancer refers to cases of cancer that spread beyond the prostate but haven’t developed resistance to standard hormone therapy like androgen deprivation. Learn more about prevention, screening, and treatment options for prostate cancer: buff.ly/Rgl05Bj
The @FDA.gov approved the targeted therapy belzutifan with the immunotherapy pembrolizumab, administered intravenously or subcutaneously, for certain adults with clear cell renal cell carcinoma at intermediate-high or high-risk following surgery: buff.ly/UpWY6AS
Clear cell renal cell carcinoma is the most common form of kidney cancer. Learn more about treatment options for kidney cancer: buff.ly/zvyP6KK
On our Believe in Progress podcast, Michael Hugo shared his glioblastoma journey—from innovative treatments to cancer research advocacy. During #NationalCancerSurvivorMonth, listen to Michael's tory and others that inspire hope and progress: www.youtube.com/watch?v=UDWA...
The @US_FDA approved the targeted therapy capivasertib with the hormone therapy abiraterone and the steroid prednisone for adults with PTEN-deficient metastatic androgen pathway modulation-naïve or -sensitive (mAPMN/S) prostate cancer: buff.ly/DD3a27z
The gut microbiome has received increased attention in recent years. Now researchers want to know how it might affect cancer treatment. Learn more in Cancer Today. www.cancertodaymag.org/spring-2026/... @joshuafein.bsky.social
Legal resources can help you plan for the future with a will and other documents.
On June 12, 2026, the Food and Drug Administration approved belzutifan (Welireg, Merck & Co., Inc.) in combination with pembrolizumab (Keytruda, Merck & Co., Inc.) or pembrolizumab and…
www.fda.gov
Kidney cancer, also known as renal cell carcinoma, is diagnosed in more than 73,000 people a year in the U.S. Learn more about the treatment of this cancer.
On June 12, 2026, the Food and Drug Administration approved capivasertib (Truqap, AstraZeneca) in combination with abiraterone and prednisone for adults with metastatic androgen pathway…
Submit an abstract by July 9 for the AACR Special Conference on Bridging Discovery and Clinical Impact in Pediatric Cancer (September 22-25; Philadelphia), chaired by Olivier Delattre, Annie A. Huang, David M. Langenau, and Suzanne P. MacFarland. Learn more:
buff.ly/KBDgzTO
#AACRpediatric26
